Canada: A Look Back At 2014 Trends In Product Liability Class Proceedings

Last Updated: January 14 2015
Article by Carly Cohen and Leonard Loewith

Hello 2015 - From the Cassels Brock Product Liability Group, welcome back and we hope you enjoyed some time off this holiday season. What better way to greet the new year than with a look back over trends in product liability class actions from 2014.

This past year, claims against pharmaceutical and medical device manufacturers were on the rise, while claims against retailers for credit card and data breaches were less frequent (and therefore there were fewer claims against manufacturers for those same breaches in relation to their products). The plaintiff-friendly landscape for certification of pharmaceutical claims may be shifting, but that has not slowed the influx of class actions commenced against pharmaceutical manufacturers.

What follows is a look back on trends in product liability class proceedings during 2014.

Pharmaceutical Product Liability

Across Canada in 2014, at least 15 class proceedings were commenced alleging the failure to warn of the risks associated with the use of prescription drugs. These pharmaceutical product liability class proceedings include the following:

  • class actions seeking national class certification were brought in British Columbia1, Alberta2, Quebec3, Manitoba4 and Nova Scotia5 against Boehringer Ingelheim as the designer, manufacturer and distributor of the blood-thinner Pradaxa;
  • in Ontario alone, four separate class proceedings against designers, manufacturers and distributors of testosterone replacement therapy, including Merck and Pfizer, were filed. These actions alleged a failure to warn of the cardiovascular risks6;
  • a series of claims in respect of Risperdal and Invega, the antipsychotic medication used to treat schizophrenia and symptoms of bipolar disorder, were brought against Janssen in Ontario7, Quebec8, Alberta9 and Nova Scotia10 alleging the failure to warn of the increased risk of developing gynecomastia;
  • the designers, manufacturers and distributors of Accutane, an acne treatment prescription, were faced with a class proceeding in Ontario11; and
  • a class proceeding regarding Topamax, a prescription used to treat seizures, was brought against Johnson & Johnson in Saskatchewan alleging the failure to warn of the associated risks, namely the risk of birth defects and vision problems.12

While none of these class proceedings have moved to the certification stage, we anticipate that the plaintiffs that move their actions forward will likely have to satisfy a more rigorous analysis to be certified in light of the Martin v Astrazeneca Pharmaceuticals PLC13 decision. In that case, Justice Horkins of the Ontario Superior Court did not certify a proposed national class action involving the antipsychotic medication Seroquel. In contrast to the low-hurdle for certification seen in previous years, the Court found that the plaintiffs failed to meet the necessary criteria and noted that the certification of similar issues in other cases is not sufficient to warrant certification in every case. So why is this decision relevant? It was upheld on appeal and suggests that Ontario courts may take a more rigorous approach in applying certification standards.

Implanted Medical Device Product Liability

Manufacturers and distributors of implanted medical products were increasing targets in class proceedings in 2014. Manufacturers in the medical device industry have been under attack for the failure to, among other things:

  • properly design and manufacture the implanted medical device;
  • conduct adequate testing before placing the device on the market; and
  • warn of the risks associated with implanting the medical device.

In two Quebec proceedings,14 the plaintiffs brought claims against the manufacturers and distributors of pelvic mesh products implanted in the uteri of female patients. Actions for defective implanted hip replacement devices also continued into 2014. In Mary Chipman v Biomet, Inc. et al,15 a Nova Scotia action, the plaintiff seeks to certify class proceedings against the manufacturer of the hip implant system. Similar claims were also brought against Biomet16 and Smith & Nephew in 2013.17

The actions come on the coattails of the Depuy decision18, in which the Ontario Superior Court certified a class action against a manufacturer of surgically implanted hip replacements. The case marked a more generous approach to the certification of medical device class actions after a series of earlier cases that had applied a more cautious approach. In light of the certification, we expect that other implanted medical devices will come under fire, but it stands to be seen whether the actions will continue to be met with plaintiff-friendly courts.

Credit Card and Data Breach Product Liability

In the past years, credit card and data breaches by hackers have been noted frequently in the media, which has resulted in a flurry of class proceedings. While 2014 saw a decline in these attacks and corresponding class actions, manufacturers of hardware must still take caution that their products meet all necessary security requirements.

From 2011 to 2013, we saw many class actions filed following data breaches. The first was commenced against Sony Playstation Network after a privacy breach of millions of its users. In this case, the class members alleged negligence in the storage and security of their credit card data. We also saw a class proceeding commenced on behalf of all Canadian residents whose electronic data and communications were intercepted by Google Street View vehicles between 2009-2010,20 alleging intentional or negligent interception of data.

TD Auto Finance Services' loss of a data tape containing customers' personal and credit information led to a class proceeding in 2012.21 Members of the class claimed that they fell victim to identity fraud before the company notified those at risk.

When a portable hard drive was stolen in late 2012, 583,000 Canada Student Loan borrowers had finance and credit information compromised, including their SIN numbers.22 Negligence and breach of confidence and fiduciary duty were pleaded in the subsequent class action. Another class action was filed in the Federal Court for breach of contract, breach of warranty, breach of confidence, reckless intrusion upon seclusion and negligence.23

To date, there have been 641 reported breaches of consumer data in the U.S. alone.24 Data breaches are no less prevalent in Canada: 36% of IT professionals surveyed reported that their companies had been the targets of data breaches.25

Most notably in 2014, hackers stole the card data of 56 million Home Depot customers. Despite an increase in data breaches in 2014, class action litigation alleging damages from negligence and intrusion into one's privacy has decreased.26 In 2014, only the Home Depot class action was commenced. In that case, customers who used credit or debit cards between April and August 2014 claimed for damages.

Despite the trend of class actions being commenced in respect of data breaches, there has been a drop off in such claims in 2014. Why? One reason could be the lack of certainty among plaintiff-side class action firms as to whether these proceedings will be certified – none of the above mentioned cases have been tested by the courts.

It is hard to say if a class action is the best method for data breach claims. In assessing whether a class action is the preferable means, the courts will consider whether the process will achieve a just and effective remedy. With the increase of data breach incidences, companies have become better at recognizing breaches and taking immediate steps to remedy potential damage. When a company recognizes a breach of confidential data, notifies its customers promptly and implements remedies to mitigate or prevent losses, the courts may view these steps as an appropriate and efficient substitute to a class proceeding.

While there remains a risk of data breaches, the trend of class proceedings following such breaches will continue to be selective, due, in part, to the proactive and face-saving steps taken by some of the companies under attack.


1. Marilyn Tanguay, Personal Representative of the Estate of Gladys Choinard, Deceased v Boehringer Ingelham (Canada) Ltd et al, (Supreme Court of British Columbia), Court File No. S-145515; George Stathis v Boehringer Ingelham (Canada) Ltd et al, Supreme Court of British Columbia, Court File No. 14-2104.

2. Dimitre Stoianov Karpuzov v Boehringer Ingelham (Canada) Ltd et al, Court of Queen's Bench of Alberta, Court File No. 1401-09615.

3. Denis Lebel v Boehringer Ingelham (Canada) Ltd et al, Quebec Superior Court (Class Action), Court file no. 500-06-000.

4. The Estate of Susan Darlene Gareau et al v Boehringer Ingelham (Canada) Ltd et al, Manitoba Court of Queen's Bench, Court File No. C114.01.87568.

5. Dawn Rae Downton as executor of the Estate of Marion Wiseman v Boehringer Ingelham (Canada) Ltd et al, Supreme Court of Nova Scotia, Court File No. 428996.

6. Nault v Merck & Co, Inc et al, Ontario Superior Court of Justice, Court File No. 3969/14CP; Edward Michael Gater et al v Pfizer Inc et al, Ontario Superior Court of Justice, Court File No. 3737/14CP; Marie Anne Tonasket Denommee v Endo Pharmaceuticals Solutions Inc et al, Ontario Superior Court of Justice, Court File No. 3704CP/14; Norman Douglas Wise et al v Abbott Laboratories, Limited at al, Ontario Superior Court of Justice, Court File No. 3547/14CP.

7. Nicholas Brown v Janssen Inc et al, Ontario Superior Court of Justice, Court File No. CV-14-496160-00CP.

8. Lebouthillier et al v Janssen Inc et al, Superior Court of Quebec (Class Action ), Court File No. unknown.

9. Joel Avery Macdonald v Janssen Inc et al, Court of Queen's Bench of Alberta, Court File No. 1401-08697.

10. Ryan Hanna v Janssen Inc et al, Supreme Court of Nova Scotia, Court File No. 429715.

11. Brad Stevenson v. Hoffman-La Roche Limited, Ontario Superior Court of Justice, Court File No. CV-10-41206500CP.

12. Barbara Reiner v Johnson & Johnson et al, Court of Queen's Bench for Saskatchewan, Court File No.QBG-578

13. Martin v Astrazeneca Pharmaceuticals Plc, 2012 ONSC 2744, upheld 2013 ONSC 1169.

14. Sharon Rosemary McKee & Hans McKee c. Tyco Healthcase Group Canada ULC d/b/a/ Covidien, Quebec Superior Court (Class Action), Court File No. 200-06-000173-149; Pauline Sirois & Réjean Dumont c. American Medical Systems Canada inc. et al., Quebec Superior Court (Class Action), Court File No. 200-06-000178-148.

15. Mary Chipman v Biomet, Inc et al, Supreme Court of Nova Scotia, Court File No. 426867.

16. Steven Dalton Dine v Biomet, Inc et al, Ontario Superior Court of Justice, Court File No. CV-10-415755-00CP.

17. Gary Carlson v Smith & Nephew Inc. of Canada et al, Supreme Court of British Columbia, Court File No. S-139332; Milana Warner v Smith & Nephew Inc, Court of Queen's Bench of Alberta, Court File No. 1301 01931.

18. Crisante v DePuy Orthopaedics Inc, 2013 ONSC 5186.

19. Youval Benabou v Sony of Canada Ltd., Sony Computer Entertainment America LLC, and Sony Network Entertainment International LLC, 2011, Quebec Superior Court (Class Action), Court File No. 500-06-000566-113.

20. M Elkoby v Google, Inc. and Google Canada Corporation, 2011, Quebec Superior Court (Class Action), Court File No. 500-06-000567-111.

21. M Belley v TD Auto Finance Services Inc., 2012, Quebec Superior Court (Class Action), Court File No. 500-006-06-000615-126.

22. Tonia Bogart v The Minister of Human Resources and Skills Development Canada and The Attorney General of Canada, 2013, Court of Queen's Bench of Alberta, Action Number 1301-00732.

23. Gaelen Patrick Condon, Rebecca Walker, and Angela Piggot v Her Majesty the Queen, 2013, Federal Court (Proposed Class Proceeding), Court File No. T-132-13.


25. Paddon, David, Data Breaches Rampant in Canada (19 August 2014), online: The Hamilton Spectator (

26. 2014 Data Breaches (23 October 2014), online: Identity Theft Resource Center (

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Carly Cohen
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions